About: Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1987

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1987 (uk) article scientifique publié en 1987 (fr) im Juli 1987 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1987 (ast) scientific article published on 01 July 1987 (en)
publication date	wds:Q70348997-8E51D4B5-043F-47E2-90A0-96A6626CC05E
publication date	1987-07-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q70348997-17E158E7-AA67-4002-92CB-D647EA1FA3D6 wds:Q70348997-214AE200-35E9-40C4-92A3-B041D2172A4F wds:Q70348997-4DE84B94-0707-4802-A02A-422CD723C6EC wds:Q70348997-58AA7034-F2EB-4040-8E5E-460865A8A812 wds:Q70348997-658B39EB-07CC-46AF-9FF6-A274D6180D0E wds:Q70348997-6FC5062E-95D3-427D-8308-60BB7DAC729E wds:Q70348997-725E5587-A1DC-4ACE-99A1-312F8C8589EF wds:Q70348997-75715A55-78FE-4741-BF23-8A02BA92AE4F wds:Q70348997-874B74BA-2C48-47A6-9FD8-09B72D870A3F wds:Q70348997-89FA77E9-4AEE-46CC-897C-42A5B5F0A669 wds:Q70348997-963E9524-CDF2-47FB-B19E-4EF8B290E365 wds:Q70348997-9F947464-1AE9-45BE-ADD0-6BEE4DE8E861 wds:Q70348997-B522CFD8-62A8-42D2-8AF6-51F370D09576 wds:Q70348997-B928D025-78F8-4E6F-AFA1-E9CAB5784A50 wds:Q70348997-C4E694BC-9EE7-4EE5-9EB7-A71295319548 wds:Q70348997-CA17A087-462B-480C-B478-BBB7DBAAA8BC wds:Q70348997-D92DCC92-9DEE-44B6-9400-1918DE138A2A wds:Q70348997-E3CD8370-0795-4653-A02E-C842B50971CA wds:Q70348997-F8CB149B-FBE5-4C2C-92E2-7F3182275353
cites work	Passive transfer of diabetes in the BB/W rat Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat Cyclosporin prevents diabetes in BB Wistar rats The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies Spontaneous Diabetes Mellitus: Reversal and Prevention in the BB/W Rat with Antiserum to Rat Lymphocytes Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats Mechanism of glucose-induced insulin secretion The Onset and Progression of Pancreatic Insulitis in the Overt, Spontaneously Diabetic, Young Adult BB Rat Studied by Pancreatic Biopsy Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mA Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor Insulin recovery in pancreas and host organs of islet grafts Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin Introducing a monoclonal antibody to insulin: the islets of Langerhans as a model for immunocytochemistry
author name string	wds:Q70348997-2247F80E-1D3E-4F7F-B38A-373A9EFABF30 wds:Q70348997-3B746790-A89D-4990-96AE-7BD73E9A79AD wds:Q70348997-3F74D88D-7221-44EB-85DF-56A10E29ED46 wds:Q70348997-6C1B0981-EA42-4337-B8DA-D5B4B9C75300 wds:Q70348997-9352533D-2A67-4E82-A72A-9818E9668A60 wds:Q70348997-F437A7D5-6B49-48E1-8617-1D7394363B79
author name string	Volk HD Diamantstein T Klöting I Hahn HJ Lucke S Baehr RV
rdfs:label	Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (en) Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (nl)
skos:prefLabel	Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (en) Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (nl)
name	Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (en) Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (nl)
title	wds:Q70348997-F90DF3BB-702C-439F-98E7-7C3A0C0CF6EC
title	Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A (en)
page(s)	wds:Q70348997-B484F329-BB10-4483-A4B0-7845BF345D49
page(s)	1075-1078
instance of	wds:Q70348997-C7B10243-D023-425B-97FA-81688AD58BD0
instance of	scholarly article
main subject	wds:Q70348997-DB32548B-EF80-4710-877B-EE2AAF6DE3AF
main subject	cyclosporine
PubMed ID	wds:Q70348997-BA914DFF-2797-4CDC-AD61-66F76B367A6F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3111859
PubMed ID	3111859
published in	wds:Q70348997-7A2D92DF-5137-4346-B0D1-ED7D6FFE9B51
published in	European Journal of Immunology
issue	wds:Q70348997-F63D0355-8F56-4FFF-B915-D3FE10CD69D2
volume	wds:Q70348997-09BD1079-65AD-4A25-8784-03185E9992D7
issue	7
volume	17
DOI	wds:Q70348997-8EF923DE-11E1-4FC1-A69C-43E745B6162E
DOI	http://dx.doi.org/10.1002/EJI.1830170728
DOI	10.1002/EJI.1830170728
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70348997
is cites work of	Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats Cytokines and autoimmune disease Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma Cellular basis of T-cell autoreactivity in autoimmune diseases Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors The Soluble Receptor of Interleukin 2 is Not a Serum Marker of the Autoimmune Activity in Type I Diabetes Mellitus Endocrine pancreas histology of congenic BB-rat strains with reduced diabetes incidence after genetic manipulation on chromosomes 4, 6 and X Immunotherapy through the IL-2 receptor Experimental immunoprevention of type I diabetes mellitus Inherent β-Cell Dysfunction Induced by Transgenic Expression of Allogeneic Major Histocompatibility Complex Class I Antigen in Islet Cells The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels. Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software